Medtronic plc (MDT) operating KPIs

MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24

Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 19/303% below fair value

$96.54−0.57 (-0.59%)

Close on Oct 30, 2026Market cap $123.49BP/E 23.7Yield 2.94%

Medtronic fDA Device Enforcement Reports — Medtronic

Quarterly figures from Medtronic's filings and investor materials

Quarterly Annual Monthly

Latest, Q1 FY27

Period ended Jul 31, 2026

Change on a year earlier

+228.6%

7 in Q1 FY26

History

51 quarters

Since Q3 FY14

Sources

U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

Period	Ended	FDA Device Enforcement Reports — Medtronic	Year on year	Source
Q1 FY27	Jul 31, 2026	23	+228.6%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY26	Apr 30, 2026	17	-5.6%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY26	Jan 31, 2026	10	-9.1%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY26	Oct 31, 2025	6	-45.5%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY26	Jul 31, 2025	7	-83.7%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY25	Apr 30, 2025	18	+125.0%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY25	Jan 31, 2025	11	-52.2%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY25	Oct 31, 2024	11	+37.5%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY25	Jul 31, 2024	43	-67.4%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY24	Apr 30, 2024	8	-68.0%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY24	Jan 31, 2024	23	+130.0%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY24	Oct 31, 2023	8	-42.9%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY24	Jul 31, 2023	132	+450.0%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY23	Apr 30, 2023	25	+316.7%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY23	Jan 31, 2023	10	-41.2%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY23	Oct 31, 2022	14	+16.7%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY23	Jul 31, 2022	24	-63.1%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY22	Apr 30, 2022	6	-77.8%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY22	Jan 31, 2022	17	-10.5%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY22	Oct 31, 2021	12	+140.0%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY22	Jul 31, 2021	65	+140.7%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY21	Apr 30, 2021	27	0.0%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY21	Jan 31, 2021	19	+26.7%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY21	Oct 31, 2020	5	-97.4%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY21	Jul 31, 2020	27	+237.5%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY20	Apr 30, 2020	27	+107.7%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY20	Jan 31, 2020	15	+150.0%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY20	Oct 31, 2019	195	+1,200.0%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY20	Jul 31, 2019	8	-88.9%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY19	Apr 30, 2019	13	-40.9%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY19	Jan 31, 2019	6	-33.3%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY19	Oct 31, 2018	15	-37.5%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY19	Jul 31, 2018	72	+323.5%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY18	Apr 30, 2018	22	-15.4%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY18	Jan 31, 2018	9	-10.0%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY18	Oct 31, 2017	24	-48.9%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY18	Jul 31, 2017	17	+30.8%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY17	Apr 30, 2017	26	+136.4%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY17	Jan 31, 2017	10	+42.9%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY17	Oct 31, 2016	47	+291.7%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY17	Jul 31, 2016	13	+160.0%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY16	Apr 30, 2016	11	+83.3%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY16	Jan 31, 2016	7	-75.9%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY16	Oct 31, 2015	12	+71.4%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY16	Jul 31, 2015	5	-58.3%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY15	Apr 30, 2015	6	-60.0%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY15	Jan 31, 2015	29	–	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY15	Oct 31, 2014	7	–	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY15	Jul 31, 2014	12	–	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY14	Apr 30, 2014	15	–	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY14	Jan 31, 2014	0	–	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗

Cite this data

StockData. (2026). Medtronic FDA Device Enforcement Reports — Medtronic, quarterly Q3 FY14–Q1 FY27 [Data set]. Compiled from Medtronic SEC filings and investor materials. https://stockdatahq.com/stocks/mdt/kpis/ext-fda-enf-co

See every metric in the Medtronic KPI table. Data updated Oct 31, 2026.